Speakers

Susanne Kintscher

Ph.D., MS&T Lead Lentiviral Vector Manufacturing • Miltenyi Bioindustry

Susanne Kintscher conducted her PhD at the German Cancer Research Center in Heidelberg, Germany in the research area of therapeutic targeting of Human Papillomaviruses. She joined Miltenyi in 2011 and currently, as a lead for the MS&T team for lentiviral vector manufacturing for ex-vivo gene therapies, she is working with her colleagues to drive process validation strategies toward marketing authorization approval. Her focus is on translating process knowledge into GMP manufacturing in the challenging field of enhanced validation approaches and regulatory requirements for ATMPs. 

Also speaking

Lydia Frick

Manager Market Access • SKC Beratungsgesellschaft mbH

Lior Raviv

Chief Technology Officer • Pluri

Ingrid Gafanhão

Equity Research Analyst, Healthcare • Bryan, Garnier & Co.

Event Info

Image

Sample Attendee List – 2024

Download and explore the 2024 Floorplan for Advanced Therapies Europe here.
Image

Enquire to Sponsor/Exhibit

Take a look at the sample attendee list for Advanced Therapies Europe 2024 here.